New Stroke Guidelines Expand Treatment Window to 24 Hours

When Dr. Jeffrey Rajchel collapsed on his bathroom floor in the middle of the night in 2022, he couldn't reach his phone for help. By the time his wife found him the next morning, the then-72-year-old surgeon had passed the 4.5-hour window to receive clot-busting medication, leaving him with severe loss of movement on his dominant left side.

Starting in January 2026, patients like Rajchel now have up to 24 hours to receive treatment for acute ischemic stroke, the type caused by blood clots blocking flow to the brain. The updated guidelines from the American Stroke Association expand access to existing treatments based on advanced imaging technology.

"We have treatments available that are very time sensitive, and the earlier you get treated, the better," said Erin Cekovich, stroke program manager at Penn State Health. The expanded window doesn't introduce new drugs but allows doctors to use proven medications for patients who previously would have been denied treatment.

The change particularly benefits people who experience strokes while asleep. Under old guidelines, these patients often arrived at hospitals too late for intervention. Now, if imaging shows salvageable brain tissue, they can still receive the clot-dissolving medication.

Stroke affects more than 795,000 Americans each year and remains the fourth leading cause of death in the country. An ischemic stroke occurs when a blood clot blocks oxygen to brain cells, which quickly begin to die without treatment.

Doctors emphasize the expanded window doesn't mean patients should delay seeking help. The benefits of clot-busting medication decrease over time while risks increase, making immediate medical attention still critical for the best outcomes.

The Ripple Effect

For Rajchel, the new guidelines came too late for his own recovery. But with a vagus nerve stimulator implant and ongoing physical therapy, he's regained much of his left-sided motor function and can still enjoy golf with friends' assistance. He sees the massive impact these guidelines will have for future patients, including shorter rehabilitation times and better outcomes.

"If I had been able to receive the medication, I'd be living a very different life right now," Rajchel said. His experience now serves as hope for countless others who will benefit from the extended treatment window, potentially avoiding the long road to recovery he faced.

Thousands of stroke patients who previously had no treatment options now have a fighting chance at full recovery.